ChemicalBook--->CAS DataBase List--->2955634-67-8

2955634-67-8

2955634-67-8 Structure

2955634-67-8 Structure
IdentificationBack Directory
[Name]

(R)-SKBG-1
[CAS]

2955634-67-8
[Synonyms]

(R)-SKBG-1
[Molecular Formula]

C22H26ClN3O6S
[MOL File]

2955634-67-8.mol
[Molecular Weight]

495.98
Chemical PropertiesBack Directory
[density ]

1.350±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)
[storage temp. ]

-10 to -25°C
[solubility ]

DMSO: 2mg/mL, clear
[form ]

Solid
[pka]

13.71±0.20(predicted)
[color ]

Light yellow to yellow
Safety DataBack Directory
[WGK Germany ]

WGK 3
[Storage Class]

11 - Combustible Solids
Hazard InformationBack Directory
[Uses]

(R)-SKBG-1 is a covalent inhibitor targeting the RNA binding protein NONO. (R)-SKBG-1 can reduce the expression of androgen receptor (AR) and its splice variants, inhibiting cancer cell proliferation. (R)-SKBG-1 inhibits androgen receptor expression with IC50 of 3.1 μM and 5.5 μM for AR-FL mRNA and AR-V7 mRNA, respectively. (R)-SKBG-1 interferes with the gene regulatory network of cancer cells and inhibits cancer cell growth by stabilizing the interaction between NONO and mRNA. (R)-SKBG-1 can be used in the study of cancers related to NONO dysfunction, such as prostate cancer[1][2][3].
[Biological Activity]

Cell permeable high affinity ligand of RNA-binding protein NONO; stabilize NONO–RNA interactions and rapidly reduces the expression of transcripts encoding AR and AR variants.


(R)-SKBG-1 is a cell permeable high affinity ligand of RNA-binding protein NONO th at binds to Cys 145 of NONO and stabilize NONO–RNA interactions. (R)-SKBG-1 rapidly and stereoselectively reduces the expression of transcripts encoding the androgen receptor (AR) and its splice variants in prostate cancer cells.
[References]

[1] Kathman SG, et al. Remodeling oncogenic transcriptomes by small molecules targeting NONO. Nat Chem Biol. 2023 Jul;19(7):825-836. DOI:10.1038/s41589-023-01270-0
[2] Takeiwa T, et al. Role of RNA binding proteins of the Drosophila behavior and human splicing (DBHS) family in health and cancer. RNA Biol. 2024 Jan;21(1):1-17. DOI:10.1080/15476286.2024.2332855
[3] Schmeing S, et al. Challenges in Therapeutically Targeting the RNA-Recognition Motif. Wiley Interdiscip Rev RNA. 2024 Nov-Dec;15(6):e1877. DOI:10.1002/wrna.1877
2955634-67-8 suppliers list
Company Name: ShangHai ChuanQian Chemcial Technique Centre  
Telephone: 15869524721
Website: www.chemicalbook.com/ShowSupplierProductsList68594/0_EN.htm
Company Name: cjbscvictory  
Telephone: 13348960310 13348960310
Website: www.weikeqi-biotech.com/
Company Name: Wuhan Jingkangen Biomedical Technology Co., Ltd  
Telephone: 13720134139 086-15871494362 13720134139
Website: https://www.jknbiochem.com
Company Name: Nantong QuanYi Biotechnology Co., Ltd  
Telephone: 0513-66337626 18051384581
Website: https://www.chemhifuture.com/
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Telephone: 021-65675885 18964387627
Website: http://www.efebio.com
Company Name: Zibo Hangyu Biotechnology Development Co., Ltd  
Telephone: 13053322091 13053322091
Website: www.chemicalbook.com/showsupplierproductslist1804467/0_en.htm
Company Name: TargetMol  
Telephone: 400-821-0310 15002144251
Website: www.targetmol.cn/
Company Name: NANJING YINGWEN BIOTECHNOLOGY CO LTD  
Telephone: +86-13382787392
Website: www.aeechem.com/
Tags:2955634-67-8 Related Product Information
2955634-67-8 221054-79-1 1949837-12-0 84633-29-4 173075-45-1 2955618-24-1